Inventor · disambiguated record
Szymon Klossowski
Also filed as: KLOSSOWSKI SZYMON
14 granted patents·4 pending applications·74 citations·filing 2011–2025
91Inventor score
Top patents by PatentIndex Score
18 records- 0196US11673898B2Substituted inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2020·Granted Jun 13, 2023·6 cites·27 claims
- 0296US10781218B2Substituted inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2017·Granted Sep 22, 2020·16 cites·20 claims
- 0396US10077271B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2017·Granted Sep 18, 2018·14 cites·18 claims
- 0495US11147885B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2020·Granted Oct 19, 2021·5 cites·20 claims
- 0594US10632209B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Apr 28, 2020·9 cites·18 claims
- 0693US10752639B2Bridged bicyclic inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2017·Granted Aug 25, 2020·8 cites·14 claims
- 0792US10174041B2Methods and compositions for inhibiting the interaction of menin with MLL proteinsKURA ONCOLOGY INC·Filed 2018·Granted Jan 8, 2019·11 cites·24 claims
- 0889US11833210B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Dec 5, 2023·1 cites·19 claims
- 0989US11786602B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 1087US11110177B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Sep 7, 2021·2 cites·16 claims
- 1185US12285490B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 1284US11555041B2Bridged bicyclic inhibitors of menin-MLL and methods of useKURA ONCOLOGY INC·Filed 2020·Granted Jan 17, 2023·1 cites·10 claims
- 1368US2025304589A1Methods and compositions for inhibiting the interaction of menin with mll proteinsKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1467US2025320225A1Substituted inhibitors of menin-mll and methods of useKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1566US2025340566A1Bridged bicyclic inhibitors of menin-mll and methods of useKURA ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1664US2024245645A1Ash1l inhibitors and methods and treatment therewithUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 1751US11883381B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 30, 2024·0 cites·13 claims
- 1825US9018255B2Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase systemOSTASZEWSKI RYSZARD·Filed 2011·Granted Apr 28, 2015·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Szymon Klossowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →